Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2019 | Challenges after CAR T-cell therapy

Here, David Maloney, MD, PhD, of Fred Hutchinson Cancer Research Center, Seattle, WA, explains the challenges that are faced in the management of patients that undergo CAR T-cell therapy. Dr Maloney was speaking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.